- Abcam - a global leader in the supply of protein research and detection tools - has completed the acquisition of of MitoSciences, a leading provider of mitochondrial research tools based in the US.

The total consideration for MitoSciences - a privately held company - is $6.0m, which is being paid in cash and shares.

Headquartered in Eugene, Oregon, MitoSciences began operations seven years ago and currently employs 24 staff.

With a catalogue of more than 200 products, it is recognised as one of the leading providers of mitochondrial research tools focusing on areas of metabolism and apoptosis.

At 8:42am: [LON:ABC] New City High Yield Trust Plc. share price was -0.37p at 398.38p

Story provided by